期刊文献+

蚌埠市维持血液透析患者钙磷代谢及全段甲状旁腺激素控制情况横断面调查 被引量:13

A cross-sectional survey on the control of the metabolism of calcium and phosphorus and the level of parathyroid hormone in maintained hemodialysis patients in Bengbu City
原文传递
导出
摘要 目的了解蚌埠市维持性血液透析患者钙磷代谢及全段甲状旁腺激素(intact parathyroid hormone,i PTH)控制情况。方法问卷调查蚌埠市蚌埠医学院第一、第二附属医院血液透析治疗>3个月的患者,记录患者一般人口学资料、合并症,测定血清钙磷及i PTH水平,分析维持性血液透析患者校正血钙、血磷、钙磷乘积和i PTH达标率,并分析血清i PTH水平与血红蛋白(hemoglobin,Hb)、血钙、血磷、钙磷乘积等临床资料相关性。结果本研究纳入170例维持性血液透析患者,以2003年KDOQI CKD-MBD指南为依据,校正血钙、血磷、钙磷乘积和i PTH的达标率分别为44.7%、44.1%、71.3%和27.6%。血清i PTH水平与年龄、Hb及血钙水平呈负相关,与血肌酐水平呈正相关。结论蚌埠市维持性血液透析患者血清钙磷及i PTH控制不理想;低血钙、低血红蛋白水平可能是i PTH升高的危险因素。 Objective To investigate the control effect of serum calcium,phosphorus and intact parathyroid hormone( i PTH) in the maintained hemodialysis patients in Bengbu. Methods Maintained hemodialysis patients who had dialyzed for more than 3 months from the first and the second affiliated hospital of Bengbu Medical College were enrolled in this cross-sectional study. The demographic data,complications were collected and serum calcium,phosphorus and i PTH were analyzed. The achievement of serum calcium,phosphorus and i PTH were calculated according to 2003 K / DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease or 2009 KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of Chronic Kidney Disease-Mineral and Bone Disorder( CKDMBD). The relationship between i PTH and clinical data such as Hb,serum calcium,serum phosphorus,and multiplications were also analyzed. Results A total of 170 maintained hemodialysis patients were included in the study. In accordance with standards in K / DOQI CKD-MBD,2003,44. 7% samples of serum calcium concentration,44. 1% serum phosphate,71. 3% calcium-phosphorus product and 27. 6% i PTH met the standards. The i PTH levels were negatively correlaed with age,Hb,serum calcium levels and positive correlated with serum creatinine levels. Conclusions The controlling of serum calcium,phosphorus and i PTH levels in the maintained hemodialysis patients seems not to be ideal in Bengbu city.These results suggested that low serum calcium levels and low hemoglobin levels may be involved in high i PTH.
出处 《中华疾病控制杂志》 CAS CSCD 北大核心 2015年第3期295-298,共4页 Chinese Journal of Disease Control & Prevention
关键词 肾透析 甲状旁腺素 流行病学 Renal dialysis Parathyroid hormone Epidemiology
  • 相关文献

参考文献8

  • 1Pencak Przemys?aw,Czerwieńska Beata,Ficek Rafa?,Wyskida Katarzyna,Kujawa-Szewieczek Agata,Olszanecka-Glinianowicz Magdalena,Wi?cek Andrzej,Chudek Jerzy.Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC nephrology . 2013
  • 2Battistella M,Richardson R M A,Bargman J M,Chan C T.Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease. Clinical Nephrology . 2011
  • 3Chertow G M,Plone M,Dillon M A,Burke S K,Slatopolsky E.Hyperparathyroidism and dialysis vintage. Clinical Nephrology . 2000
  • 4Kidney Disease:Improving Global Outcomes (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International Supplement . 2009
  • 5National Kidney Foundation.K/DOQI clinical practice guide-lines for bone metabolism and disease in chronic kidney dis-ease. American Journal of Kidney Diseases . 2003
  • 6Brown E M,MacLeod R J.Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews . 2001
  • 7Masafumi Fukagawa,Masafumi Kitaoka,Hung Yi,Naoko Fukuda,Toshio Matsumoto,Etsuro Ogata,Kiyoshi Kurokawa.Serial Evaluation of Parathyroid Size by Ultrasonography Is Another Useful Marker for the Long-Term Prognosis of Calcitriol Pulse Therapy in Chronic Dialysis Patients. Nephron . 1994
  • 8孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63

二级参考文献18

  • 1Lemann JJ, Litzow JR, Lennon EJ. The effect of chronic acid loads in normal man: Further evidence against chronic metabolic acidosis[J]. J Clin Invest, 1966, 45:1608-1614
  • 2Lemann JJ, Litzow JR, Lennon EJ. Studies of the mechanism by which chronic metabolic acidosis augment urinary calcium excretion in man[J]. J Clin Invest, 1967, 46:1318-1328
  • 3Craig BL. Calcitriol metabolism during chronic metabolic acidosis[J]. Semin Nephrol, 1989, 9:65-71
  • 4Kurz P, Monier Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease[J]. Kidney Int, 1994, 46:855-861
  • 5Nakano Y, Oshima T, Sasaki S, et al. Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration[J]. J Mol Med, 2000, 78:575-579
  • 6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calciumХphosphorus product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney Dis, 1998, 31: 607-617
  • 7Amann K, Gross ML, London GM, et al. Hyperphosphataemia-a silent killer of patients with renal failure[J]? Nephrol Dial Transplant, 1999, 14:2085-2087
  • 8Brenner BM. The Kidney[M]. 北京: 科学出版社,2001. 520-556
  • 9Goldfarb S. Renal osteodystrophy, disorders of divalent ion metabolism, and nephrolithiasis[J]. Nephrology Self-Assessment Program, 2002, 1: 55-68
  • 10Cannata-Andia JB. Pathogenesis, prevention and management of low-bone turnover[J]. Nephrol Dial Transplant, 2000, 15(Suppl 5): 15-17

共引文献62

同被引文献88

  • 1Thanh-Mai Vo,Sinee Disthabanchong.Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?[J].World Journal of Cardiology,2014,6(5):216-226. 被引量:5
  • 2涂曦文,彭佑铭,唐东兴,谭太发,李丽文.维持性血液透析患者血管钙化及相关因素分析[J].中国动脉硬化杂志,2015,23(6):613-616. 被引量:24
  • 3Tajbakhsh R, Joshaghani HR, Bayzayi F, et al. Association between pruritus and serum concentrations of parathormone, calcium and phosphorus in hemodialysis patients [J]. Saudi J Kidney Dis Transpl, 2013,24 (4) : 702-706.
  • 4Nikodimopoulou M, Liakos S. Secondary hyperparathyroidism and target organs in chronic kidney disease [J ]. Hippokratia, 201 l, 15 (Suppl 1 ) : 33-38.
  • 5Wald R, Tentori F, Tighiouart H, et al. Impact of the Kidney Disease outcomes Quality Initiative (KDOQI)Clinical practice Guidelines for Bone Metabolism and Disease in a large dialysis network [ J ]. Am I Kidney Dis, 2007,49 ( 3 ) : 257-266.
  • 6Dialysis Outcomes and Practice Patterns Study. 2010 DOPPS annual report [EB/OL]. (2010-06-30) [2014-05-11 ]. http : //www. dopps, org/annum report/archives/DOPPSAR 2010/ index.htm.
  • 7Li J, Molnar MZ, Zaritsky J, et al. Correlates of parathyroid hormone concentration in hemodialysis patients [J]. Nephrol Dial Transplant, 2013,28(6) : 1516-1525.
  • 8Wahl P, Xie H, SciaUa J, et at. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease [J]. Diabetes Care, 2012,35 (5): 994-1001.
  • 9Dan S, Aditya P, Samanta M, et al. Effect of glycemic control on intact parathyroid hormone level in end renal disease patients on maintenance hemodialysis [J]. Diabetes Res Clin Pract, 2014,105 (3) : 352-355.
  • 10Motyl K J, McCauley LK, McCabe LR. Amelioration of type idiabetes-induced osteoporosis by parathyroid hormone is associated with improved osteobtast survival [J]. J Cell Physiol, 2012,227(4) : 1326-1334.

引证文献13

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部